Adverum Biotechnologies, Inc. (ADVM)
4.36
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 16:00
Adverum Biotechnologies Cash from Investing (Quarterly): 1.858M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -2.983B |
| Pfizer Inc. | -2.43B |
| Recursion Pharmaceuticals, Inc. | -2.549M |
| Quantum-Si, Inc. | -6.205M |
| X4 Pharmaceuticals, Inc. | -28.67M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -28.12M |
| Cash from Financing (Quarterly) | 9.899M |
| Free Cash Flow | -138.44M |
| Free Cash Flow Per Share (Quarterly) | -1.203 |
| Free Cash Flow to Equity (Quarterly) | -24.98M |
| Free Cash Flow to Firm (Quarterly) | -28.26M |
| Free Cash Flow Yield | -147.1% |